Filing Details
- Accession Number:
- 0001213900-25-091105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-09-24 16:01:57
- Reporting Period:
- 2025-09-22
- Filing Date:
- 2025-09-24
- Accepted Time:
- 2025-09-24 16:01:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1788028 | Jasper Therapeutics Inc. | JSPR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208907 | G Thomas Wiggans | C/O Jasper Therapeutics, Inc. 2200 Bridge Pkwy, Suite #102 Redwood City CA 94065 | Yes | No | No | No |
Transaction Summary
| Purchased: | 41,000 shares | Avg. Price: $2.43 | Total Value: $99,630.00 |
| Number of Shares After Transactions: | 41,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2025-09-22 | 41,000 | $2.43 | 41,000 | No | 4 | P | Indirect | By Wiggans Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Wiggans Living Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Voting Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2025-09-22 | 41,000 | $0.00 | 41,000 | $2.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 41,000 | 2026-03-22 | 2030-03-22 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Voting Common Stock | 5,000 | Direct |
Footnotes
- Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.